Australia's largest stock trading and investment forum Australia's #1 stock forum

MLA

Click for more information

0.00%

8.5¢ medical australia limited

Ann: Appendix 4C - quarterly, page-3

First 3 Last

Share
Profile

Follow
sydney6791

5,777 Posts.

424

25/10/17

17:59

Post #: 28192272
Share

Originally posted by imspartacus ↑

Immediate thoughts here... staff payments up (as per that comment in the SIA booklet) from circa 825k (Mar-17) to 951k this quarter.

"Employee benefit expenses is MLA's largest overhead, accounting for approximately 60-64% of overheads across the period reviewed. Employee benefits expenses have increased largely in line with sales growth, with employee expenses representing 24.1% , 24.2% and 24.5% of sales in FY 15A, FY16A and FY17A, respectively. Employee benefits expenses are budgeted to increase by $522k (16.2%) to $3.7m in FY18B, which represents 28.6% of budgeted sales. Management has advised that the increase relates to new staff hires associated with both the Tuta and Clements (including Ardo) divisions."

And surprisingly quarterly revenue's largely unchanged at $3.22m vs $3.18m Sep-16 quarter. In my view the headline cashflow reduction looks somewhat misleading, would be in line with the view that OEM revenue is on the decrease and significant gains in Ardo/Clements are continuing to offset as the sales team's experience and output gathers steam.

Solid 3.2m bid @ 8.4c still there.

all IMO, DYOR etc...

Expand

Still running at loss, $140k last quarter, and 1.3m cash left. donot know why the business is always not profitable.

MLA Price at posting: 8.4¢ Sentiment: Hold Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

MMI

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

HotCopper Highlights: Your most watched and most discussed stocks this week

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

FG1

Flynn Gold reaches milestone exploration target for Golden Ridge

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

Trump is President Again: What Does This Mean for Crypto?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

IMU

Imugene kicks off Australian trial for blood cancer treatment

First 3 Last

Add MLA (ASX) to my watchlist